← Sites
718 (USA)
USA
PI: Dr. Nolan
activated
KRI 0.05
Patients
13
Active (enrolled/consented)
0
Withdrawn
2
Serious AEs
2
Open QA findings
0
Aged data queries
0
Studies & contracts total budget 168500.00 USD
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
study completed
contract executed
168500 USD
Patients first 13
| Ref | Status | Consented | Study |
|---|---|---|---|
| 718-1066 | completed | 2013-07-07 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 718-1079 | completed | 2012-09-19 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 718-1101 | completed | 2013-02-17 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 718-1139 | completed | 2013-05-19 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 718-1150 | completed | 2013-01-19 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 718-1170 | completed | 2013-09-16 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 718-1172 | withdrawn | 2013-09-21 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 718-1250 | completed | 2013-09-21 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 718-1254 | completed | 2013-07-10 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 718-1328 | withdrawn | 2013-02-01 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 718-1355 | completed | 2013-02-28 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 718-1371 | completed | 2013-04-26 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 718-1427 | completed | 2012-12-17 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
Luna participants (0)
No participants at this site use Luna yet.
Safety 91 AEs · 2 serious
serious
718-1170
reported
Severe SYNCOPE — outcome: RECOVERED/RESOLVED; onset 2013-10-12 (study day 27.0); relationship: PROBABLE; serious criteria: hospitalization
serious
718-1371
reported
Severe PARTIAL SEIZURES WITH SECONDARY GENERALISATION — outcome: RECOVERED/RESOLVED; onset 2013-06-02 (study day 38.0); relationship: NONE; serious criteria: hospitalization
QA findings 0 open
No findings recorded.
Monitoring visits (0)
No visits recorded.
Payments (0)
No payments on file.